Pediatric Medicines-United States Market Status and Trend Report 2013-2023
Report Summary
Pediatric Medicines-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pediatric Medicines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Pediatric Medicines 2013-2017, and development forecast 2018-2023
Main market players of Pediatric Medicines in United States, with company and product introduction, position in the Pediatric Medicines market
Market status and development trend of Pediatric Medicines by types and applications
Cost and profit status of Pediatric Medicines, and marketing status
Market growth drivers and challenges
The report segments the United States Pediatric Medicines market as:
United States Pediatric Medicines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Pediatric Medicines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pills
Granules
Capsules
United States Pediatric Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Children's Hospital
Pharmacy
United States Pediatric Medicines Market: Players Segment Analysis (Company and Product introduction, Pediatric Medicines Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi
Bristol-Myers Squibb
Abbott
Novartis
Pfizer
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pediatric Medicines-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pediatric Medicines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Pediatric Medicines 2013-2017, and development forecast 2018-2023
Main market players of Pediatric Medicines in United States, with company and product introduction, position in the Pediatric Medicines market
Market status and development trend of Pediatric Medicines by types and applications
Cost and profit status of Pediatric Medicines, and marketing status
Market growth drivers and challenges
The report segments the United States Pediatric Medicines market as:
United States Pediatric Medicines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Pediatric Medicines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pills
Granules
Capsules
United States Pediatric Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Children's Hospital
Pharmacy
United States Pediatric Medicines Market: Players Segment Analysis (Company and Product introduction, Pediatric Medicines Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi
Bristol-Myers Squibb
Abbott
Novartis
Pfizer
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PEDIATRIC MEDICINES
1.1 Definition of Pediatric Medicines in This Report
1.2 Commercial Types of Pediatric Medicines
1.2.1 Pills
1.2.2 Granules
1.2.3 Capsules
1.3 Downstream Application of Pediatric Medicines
1.3.1 Hospital
1.3.2 Children's Hospital
1.3.3 Pharmacy
1.4 Development History of Pediatric Medicines
1.5 Market Status and Trend of Pediatric Medicines 2013-2023
1.5.1 United States Pediatric Medicines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Medicines Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pediatric Medicines in United States 2013-2017
2.2 Consumption Market of Pediatric Medicines in United States by Regions
2.2.1 Consumption Volume of Pediatric Medicines in United States by Regions
2.2.2 Revenue of Pediatric Medicines in United States by Regions
2.3 Market Analysis of Pediatric Medicines in United States by Regions
2.3.1 Market Analysis of Pediatric Medicines in New England 2013-2017
2.3.2 Market Analysis of Pediatric Medicines in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Pediatric Medicines in The Midwest 2013-2017
2.3.4 Market Analysis of Pediatric Medicines in The West 2013-2017
2.3.5 Market Analysis of Pediatric Medicines in The South 2013-2017
2.3.6 Market Analysis of Pediatric Medicines in Southwest 2013-2017
2.4 Market Development Forecast of Pediatric Medicines in United States 2018-2023
2.4.1 Market Development Forecast of Pediatric Medicines in United States 2018-2023
2.4.2 Market Development Forecast of Pediatric Medicines by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Pediatric Medicines in United States by Types
3.1.2 Revenue of Pediatric Medicines in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Pediatric Medicines in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pediatric Medicines in United States by Downstream Industry
4.2 Demand Volume of Pediatric Medicines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pediatric Medicines by Downstream Industry in New England
4.2.2 Demand Volume of Pediatric Medicines by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Pediatric Medicines by Downstream Industry in The Midwest
4.2.4 Demand Volume of Pediatric Medicines by Downstream Industry in The West
4.2.5 Demand Volume of Pediatric Medicines by Downstream Industry in The South
4.2.6 Demand Volume of Pediatric Medicines by Downstream Industry in Southwest
4.3 Market Forecast of Pediatric Medicines in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC MEDICINES
5.1 United States Economy Situation and Trend Overview
5.2 Pediatric Medicines Downstream Industry Situation and Trend Overview
CHAPTER 6 PEDIATRIC MEDICINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Pediatric Medicines in United States by Major Players
6.2 Revenue of Pediatric Medicines in United States by Major Players
6.3 Basic Information of Pediatric Medicines by Major Players
6.3.1 Headquarters Location and Established Time of Pediatric Medicines Major Players
6.3.2 Employees and Revenue Level of Pediatric Medicines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PEDIATRIC MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GSK
7.1.1 Company profile
7.1.2 Representative Pediatric Medicines Product
7.1.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Pediatric Medicines Product
7.2.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 Bristol-Myers Squibb
7.3.1 Company profile
7.3.2 Representative Pediatric Medicines Product
7.3.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.4 Abbott
7.4.1 Company profile
7.4.2 Representative Pediatric Medicines Product
7.4.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Abbott
7.5 Novartis
7.5.1 Company profile
7.5.2 Representative Pediatric Medicines Product
7.5.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Novartis
7.6 Pfizer
7.6.1 Company profile
7.6.2 Representative Pediatric Medicines Product
7.6.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Pfizer
7.7 Cipla
7.7.1 Company profile
7.7.2 Representative Pediatric Medicines Product
7.7.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Cipla
7.8 Eisai Pharmaceuticals
7.8.1 Company profile
7.8.2 Representative Pediatric Medicines Product
7.8.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eisai Pharmaceuticals
7.9 Eli Lilly
7.9.1 Company profile
7.9.2 Representative Pediatric Medicines Product
7.9.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eli Lilly
7.10 F. Hoffman-La Roche
7.10.1 Company profile
7.10.2 Representative Pediatric Medicines Product
7.10.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of F. Hoffman-La Roche
7.11 Glenmark
7.11.1 Company profile
7.11.2 Representative Pediatric Medicines Product
7.11.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Glenmark
7.12 Helsinn Healthcare
7.12.1 Company profile
7.12.2 Representative Pediatric Medicines Product
7.12.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Helsinn Healthcare
7.13 Heron Therapeutics
7.13.1 Company profile
7.13.2 Representative Pediatric Medicines Product
7.13.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Heron Therapeutics
7.14 Ipca Laboratories
7.14.1 Company profile
7.14.2 Representative Pediatric Medicines Product
7.14.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Ipca Laboratories
7.15 Sun Pharmaceutical Industries
7.15.1 Company profile
7.15.2 Representative Pediatric Medicines Product
7.15.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.16 Takeda Pharmaceutical
7.17 Lupin Pharmaceuticals
7.18 Merck Sharp & Dohme
7.19 RedHill
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC MEDICINES
8.1 Industry Chain of Pediatric Medicines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC MEDICINES
9.1 Cost Structure Analysis of Pediatric Medicines
9.2 Raw Materials Cost Analysis of Pediatric Medicines
9.3 Labor Cost Analysis of Pediatric Medicines
9.4 Manufacturing Expenses Analysis of Pediatric Medicines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PEDIATRIC MEDICINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pediatric Medicines in This Report
1.2 Commercial Types of Pediatric Medicines
1.2.1 Pills
1.2.2 Granules
1.2.3 Capsules
1.3 Downstream Application of Pediatric Medicines
1.3.1 Hospital
1.3.2 Children's Hospital
1.3.3 Pharmacy
1.4 Development History of Pediatric Medicines
1.5 Market Status and Trend of Pediatric Medicines 2013-2023
1.5.1 United States Pediatric Medicines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Medicines Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pediatric Medicines in United States 2013-2017
2.2 Consumption Market of Pediatric Medicines in United States by Regions
2.2.1 Consumption Volume of Pediatric Medicines in United States by Regions
2.2.2 Revenue of Pediatric Medicines in United States by Regions
2.3 Market Analysis of Pediatric Medicines in United States by Regions
2.3.1 Market Analysis of Pediatric Medicines in New England 2013-2017
2.3.2 Market Analysis of Pediatric Medicines in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Pediatric Medicines in The Midwest 2013-2017
2.3.4 Market Analysis of Pediatric Medicines in The West 2013-2017
2.3.5 Market Analysis of Pediatric Medicines in The South 2013-2017
2.3.6 Market Analysis of Pediatric Medicines in Southwest 2013-2017
2.4 Market Development Forecast of Pediatric Medicines in United States 2018-2023
2.4.1 Market Development Forecast of Pediatric Medicines in United States 2018-2023
2.4.2 Market Development Forecast of Pediatric Medicines by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Pediatric Medicines in United States by Types
3.1.2 Revenue of Pediatric Medicines in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Pediatric Medicines in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pediatric Medicines in United States by Downstream Industry
4.2 Demand Volume of Pediatric Medicines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pediatric Medicines by Downstream Industry in New England
4.2.2 Demand Volume of Pediatric Medicines by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Pediatric Medicines by Downstream Industry in The Midwest
4.2.4 Demand Volume of Pediatric Medicines by Downstream Industry in The West
4.2.5 Demand Volume of Pediatric Medicines by Downstream Industry in The South
4.2.6 Demand Volume of Pediatric Medicines by Downstream Industry in Southwest
4.3 Market Forecast of Pediatric Medicines in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC MEDICINES
5.1 United States Economy Situation and Trend Overview
5.2 Pediatric Medicines Downstream Industry Situation and Trend Overview
CHAPTER 6 PEDIATRIC MEDICINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Pediatric Medicines in United States by Major Players
6.2 Revenue of Pediatric Medicines in United States by Major Players
6.3 Basic Information of Pediatric Medicines by Major Players
6.3.1 Headquarters Location and Established Time of Pediatric Medicines Major Players
6.3.2 Employees and Revenue Level of Pediatric Medicines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PEDIATRIC MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GSK
7.1.1 Company profile
7.1.2 Representative Pediatric Medicines Product
7.1.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of GSK
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Pediatric Medicines Product
7.2.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 Bristol-Myers Squibb
7.3.1 Company profile
7.3.2 Representative Pediatric Medicines Product
7.3.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.4 Abbott
7.4.1 Company profile
7.4.2 Representative Pediatric Medicines Product
7.4.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Abbott
7.5 Novartis
7.5.1 Company profile
7.5.2 Representative Pediatric Medicines Product
7.5.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Novartis
7.6 Pfizer
7.6.1 Company profile
7.6.2 Representative Pediatric Medicines Product
7.6.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Pfizer
7.7 Cipla
7.7.1 Company profile
7.7.2 Representative Pediatric Medicines Product
7.7.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Cipla
7.8 Eisai Pharmaceuticals
7.8.1 Company profile
7.8.2 Representative Pediatric Medicines Product
7.8.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eisai Pharmaceuticals
7.9 Eli Lilly
7.9.1 Company profile
7.9.2 Representative Pediatric Medicines Product
7.9.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eli Lilly
7.10 F. Hoffman-La Roche
7.10.1 Company profile
7.10.2 Representative Pediatric Medicines Product
7.10.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of F. Hoffman-La Roche
7.11 Glenmark
7.11.1 Company profile
7.11.2 Representative Pediatric Medicines Product
7.11.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Glenmark
7.12 Helsinn Healthcare
7.12.1 Company profile
7.12.2 Representative Pediatric Medicines Product
7.12.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Helsinn Healthcare
7.13 Heron Therapeutics
7.13.1 Company profile
7.13.2 Representative Pediatric Medicines Product
7.13.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Heron Therapeutics
7.14 Ipca Laboratories
7.14.1 Company profile
7.14.2 Representative Pediatric Medicines Product
7.14.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Ipca Laboratories
7.15 Sun Pharmaceutical Industries
7.15.1 Company profile
7.15.2 Representative Pediatric Medicines Product
7.15.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.16 Takeda Pharmaceutical
7.17 Lupin Pharmaceuticals
7.18 Merck Sharp & Dohme
7.19 RedHill
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC MEDICINES
8.1 Industry Chain of Pediatric Medicines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC MEDICINES
9.1 Cost Structure Analysis of Pediatric Medicines
9.2 Raw Materials Cost Analysis of Pediatric Medicines
9.3 Labor Cost Analysis of Pediatric Medicines
9.4 Manufacturing Expenses Analysis of Pediatric Medicines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PEDIATRIC MEDICINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
